Erin L O'Hea1,2, Samantha Creamer2, Julie M Flahive3, Beth A Keating4, Candace R Crocker2, Shannon R Williamson5, Kathryn L Edmiston6, Tina Harralson7, Edwin D Boudreaux8. 1. Department of Psychology, Stonehill College, Easton, Massachusetts, USA. 2. Department of Psychiatry, University of Massachusetts Medical School, Worcester, Massachusetts, USA. 3. Department of Population and Quantitative Health Science, University of Massachusetts Medical School, Worcester, Massachusetts, USA. 4. Department of Hematology/Oncology, University of Massachusetts Medical School, Worcester, Massachusetts, USA. 5. Department of Psychiatry, Rhode Island Hospital, Providence, Rhode Island, USA. 6. Department of Hematology/Oncology, UMass Memorial Medical Center, Worcester, Massachusetts, USA. 7. Tridiuum, Philadelphia, Pennsylvania, USA. 8. Departments of Emergency Medicine, Psychiatry, and Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Abstract
PURPOSE: The Polaris Oncology Survivorship Transition (POST) system is a computer-based program that integrates information from the electronic health record, oncology team, and the patient to produce a personalized Survivorship Care Plan. The purpose of this study was to compare the POST to treatment as usual on confidence, quality of life, and interest in mental health referrals in women ending treatment for breast cancer. SAMPLE: Two hundred women (100 POST, 100 treatment as usual) ending treatment for breast cancer were enrolled in a randomized controlled trial. DESIGN: Women randomized to the POST condition received a personalized care plan during a baseline/intervention appointment. At enrollment and baseline/intervention, a number of outcomes were examined in this study, including confidence to enter survivorship measured by the Confidence in Survivorship Index (CSI) and Quality of Life (QOL). One, three, and six month follow up assessments were also conducted. FINDINGS: Treatment groups did not differ in terms of QOL scores at any time points. Mean CSI scores were statistically different between POST and treatment as usual at baseline for the total CSI score and both subscales, but only for confidence in knowledge about prevention and treatment at the 1-month follow-up. All significant differences were in favor of the POST intervention as mean CSI scores were higher for participants who received the POST intervention as opposed to treatment as usual. These findings disappeared at the 3 and 6 month follow up assessments. Finally, patients who received the POST intervention were twice as likely to request mental health/social services referrals compared to women who received treatment as usual. IMPLICATIONS: Oncologists may use the POST to build personalized care plans for women ending treatment for cancer, which may enhance patients' confidence in the short term as well as encourage use of mental health resources.
PURPOSE: The Polaris Oncology Survivorship Transition (POST) system is a computer-based program that integrates information from the electronic health record, oncology team, and the patient to produce a personalized Survivorship Care Plan. The purpose of this study was to compare the POST to treatment as usual on confidence, quality of life, and interest in mental health referrals in women ending treatment for breast cancer. SAMPLE: Two hundred women (100 POST, 100 treatment as usual) ending treatment for breast cancer were enrolled in a randomized controlled trial. DESIGN: Women randomized to the POST condition received a personalized care plan during a baseline/intervention appointment. At enrollment and baseline/intervention, a number of outcomes were examined in this study, including confidence to enter survivorship measured by the Confidence in Survivorship Index (CSI) and Quality of Life (QOL). One, three, and six month follow up assessments were also conducted. FINDINGS: Treatment groups did not differ in terms of QOL scores at any time points. Mean CSI scores were statistically different between POST and treatment as usual at baseline for the total CSI score and both subscales, but only for confidence in knowledge about prevention and treatment at the 1-month follow-up. All significant differences were in favor of the POST intervention as mean CSI scores were higher for participants who received the POST intervention as opposed to treatment as usual. These findings disappeared at the 3 and 6 month follow up assessments. Finally, patients who received the POST intervention were twice as likely to request mental health/social services referrals compared to women who received treatment as usual. IMPLICATIONS: Oncologists may use the POST to build personalized care plans for women ending treatment for cancer, which may enhance patients' confidence in the short term as well as encourage use of mental health resources.
Entities:
Keywords:
breast cancer; quality of life; self-efficacy; survivorship care planning
Authors: Jane Turner; Patsy Yates; Lizbeth Kenny; Louisa G Gordon; Bryan Burmeister; Brett G M Hughes; Alexandra L McCarthy; Chris Perry; Raymond J Chan; Alana Paviour; Helen Skerman; Martin Batstone; Lisa Mackenzie Journal: Support Care Cancer Date: 2019-04-02 Impact factor: 3.603
Authors: Eva Grunfeld; Jim A Julian; Gregory Pond; Elizabeth Maunsell; Douglas Coyle; Amy Folkes; Anil A Joy; Louise Provencher; Daniel Rayson; Dorianne E Rheaume; Geoffrey A Porter; Lawrence F Paszat; Kathleen I Pritchard; André Robidoux; Sally Smith; Jonathan Sussman; Susan Dent; Jeffrey Sisler; Jennifer Wiernikowski; Mark N Levine Journal: J Clin Oncol Date: 2011-10-31 Impact factor: 44.544
Authors: Elizabeth A Kvale; Chao-Hui Sylvia Huang; Karen M Meneses; Wendy Demark-Wahnefried; Sejong Bae; Casey B Azuero; Gabrielle B Rocque; Kerri S Bevis; Christine S Ritchie Journal: Cancer Date: 2016-07-07 Impact factor: 6.860
Authors: Annelies H Boekhout; Elizabeth Maunsell; Gregory R Pond; Jim A Julian; Doug Coyle; Mark N Levine; Eva Grunfeld Journal: J Cancer Surviv Date: 2015-04-21 Impact factor: 4.442
Authors: Navneet S Majhail; Elizabeth Murphy; Purushottam Laud; Jaime M Preussler; Ellen M Denzen; Beatrice Abetti; Alexia Adams; RaeAnne Besser; Linda J Burns; Jan Cerny; Rebecca Drexler; Theresa Hahn; Lensa Idossa; Balkrishna Jahagirdar; Naynesh Kamani; Alison Loren; Deborah Mattila; Joseph McGuirk; Heather Moore; Jana Reynolds; Wael Saber; Lizette Salazar; Barry Schatz; Patrick Stiff; John R Wingard; Karen L Syrjala; K Scott Baker Journal: Haematologica Date: 2018-12-04 Impact factor: 9.941